1. Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor
    Ana González-Ortega et al, 2014, Peptides CrossRef
  2. Antileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells
    Samaneh Bayati et al, 2018, Anti-Cancer Drugs CrossRef
  3. Optimization of antitumor treatment conditions for transcutaneous CO2 application: An in vivo study
    Takeshi Ueha et al, 2017, Oncology Reports CrossRef
  4. Neurokinin receptor antagonism: a patent review (2014-present)
    Miguel Muñoz et al, 2020, Expert Opinion on Therapeutic Patents CrossRef
  5. The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia
    Miguel Muñoz et al, 2020, Journal of Clinical Medicine CrossRef
  6. Neurokinin-1 Receptor Antagonists against Hepatoblastoma
    Miguel Muñoz et al, 2019, Cancers CrossRef
  7. Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors
    Paweł K. Halik et al, 2020, Molecules CrossRef
  8. Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity
    Ashiq Legi et al, 2021, Cancers CrossRef
  9. The NK-1 receptor antagonist L-732,138 induces apoptosis in human gastrointestinal cancer cell lines
    Miguel Muñoz et al, 2017, Pharmacological Reports CrossRef
  10. The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?
    Miguel Muñoz et al, 2020, Cancers CrossRef
  11. Targeting tachykinin receptors in neuroblastoma
    Anton G. Henssen et al, 2017, Oncotarget CrossRef
  12. The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy
    Agnieszka Majkowska-Pilip et al, 2019, Pharmaceutics CrossRef
  13. Inhibition of tachykinin NK1 receptor using aprepitant induces apoptotic cell death and G1 arrest through Akt/p53 axis in pre-B acute lymphoblastic leukemia cells
    Samaneh Bayati et al, 2016, European Journal of Pharmacology CrossRef
  14. In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity
    Joanna Matalińska et al, 2020, International Journal of Molecular Sciences CrossRef
  15. The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs
    Miguel Muñoz et al, 2015, Journal of Biosciences CrossRef
  16. Biological and Pharmacological Aspects of the NK1-Receptor
    Susana Garcia-Recio et al, 2015, BioMed Research International CrossRef
  17. Involvement of substance P and the NK-1 receptor in human pathology
    Miguel Muñoz et al, 2014, Amino Acids CrossRef
  18. Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-κB Signal Transduction Pathways in Colon Cancer Cells
    Atefeh Ghahremanloo et al, 2021, BioMed Research International CrossRef
  19. MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ERα
    Xiaobin Liu et al, 2019, Life Sciences CrossRef
  20. G protein-coupled receptors as oncogenic signals in glioma: Emerging therapeutic avenues
    A.E. Cherry et al, 2014, Neuroscience CrossRef
  21. The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer
    MIGUEL MUÑOZ et al, 2014, International Journal of Oncology CrossRef
  22. Aprepitant Sensitizes Acute Myeloid Leukemia Cells to the Cytotoxic Effects of Cytosine Arabinoside in vitro and in vivo


    Hongzhang Wu et al, 2020, Drug Design, Development and Therapy CrossRef
  23. Truncated neurokinin-1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stage
    AGNÈS GARNIER et al, 2016, Oncology Letters CrossRef
  24. Neurokinin-1 Receptor Antagonists as Anticancer Drugs
    Miguel Muñoz et al, 2019, Letters in Drug Design & Discovery CrossRef
  25. Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists
    A. Molinos-Quintana et al, 2019, Investigational New Drugs CrossRef
  26. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo
    Michael Berger et al, 2014, Journal of Hepatology CrossRef
  27. Evaluation of the antileukemic effects of neurokinin-1 receptor antagonists, aprepitant, and L-733,060, in chronic and acute myeloid leukemic cells
    Miriş Dikmen et al, 2019, Anti-Cancer Drugs CrossRef
  28. MicroRNA Expression Changes and Integrated Pathways Associated With Poor Outcome in Canine Osteosarcoma
    Deanna D. Dailey et al, 2021, Frontiers in Veterinary Science CrossRef